ClinicalTrials.gg

Drug

Dihematoporphyrin Ether clinical trials

Also written porfimer sodium and Photofrin.

studies test it
22
open now
0
in phase 3
4
first study started
1995

How studies write it

Studies that test it under each name

Studies by the year they started

21 studies that test it; most in 1995 (2)

Studies that test Dihematoporphyrin Ether, by start year
YearStudies
19952
19992
20011
20031
20041
20052
20071
20091
20132
20141
20151
20172
20191
20201
20212

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
8
Phase 2
9
Phase 3
4
No phase
2

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 2 · Other 20

Roswell Park Cancer Institute (7) · Abramson Cancer Center at Penn Medicine (2) · Concordia Laboratories Inc. (2) · Harry T Whelan, MD (1) · John DeWitt (1) · University of Miami (1) · Samsung Medical Center (1) · Memorial Sloan Kettering Cancer Center (1)

Often tested with

Tested in the same studies.

Gemcitabine (1) · Antineoplastic Agents (1) · Ethiodized Oil (1)

Studies

Open first, then newest update. How each study uses Dihematoporphyrin Ether is read from its arms, and is right about nine times in ten.

Testing it · 22

See all 22 studies that test Dihematoporphyrin Ether →

Given in every arm · 3 — Dihematoporphyrin Ether is usual care beside what is tested

Codes

What other systems call Dihematoporphyrin Ether · ClinicalTrials.gg INT008584

  • MeSH (NLM) D017323Dihematoporphyrin EtherOne source ClinicalTrials.gov

Also registered as bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl ether (UNII 625J2HS54G · RxNorm 23066), porfimer (UNII M15H03K69B · RxNorm 333848) and porfimer sodium (UNII Y3834SIK5F · RxNorm 333848).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.